NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-128-2021-0-PCT-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS PCT PCT PCT/US2021/032782 Expired
NCI E-007-2019-0-US-05 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER US National Stage 17/294,011 Issued
NIAID E-357-2001-1-AU-35 CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2021203089 Expired
NIAID E-104-2020-0-PCT-02 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS PCT PCT PCT/US2021/32305 Expired
NIAID E-145-2021-2-PCT-01 Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza PCT PCT COMB PCT/US2021/032252 Expired
NIAID E-104-2020-0-AU-03 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS AU National Stage 2021271702 Pending
NIAID E-104-2020-0-CA-04 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS CA National Stage 3178538 Pending
NCI E-007-2019-0-CA-03 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER CA National Stage 3119736 Issued
NIAID E-139-2006-0-AU-70 Development Of Dengue Virus Vaccine Components AU DIV 2021202950 Issued
NCI E-241-2016-0-US-07 RADIOACTIVE SOURCE CALIBRATION US CON 17/314,355 11614548 Issued PDF
NIAID E-251-2020-0-PCT-02 PPMO Targeting SARS-CoV-2 Genomic RNA To Treat And Prevent Coronavirus Infection PCT PCT PCT/US2020/031335 Expired
NIAID E-128-2016-0-US-06 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES US CON 17/307,066 Pending
NCI E-053-2015-1-US-11 MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US CON 17/306,756 Abandoned
NICHD E-226-2010-0-US-05 MRI TRACTOGRAPHY BASED TRANSIT TIME DETERMINATION FOR NERVE FIBERS US CON 17/306,841 Pending
NLM E-110-2016-3-US-02 Novel CRISPR Enzymes And Systems US CON 17/246,460 Pending
NCI E-097-2018-0-HK-19 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES HK EP 62021030236.5 Pending
NLM E-110-2016-3-US-03 Novel CRISPR Enzymes And Systems US CON 17/246,466 Pending
NIDCR E-150-2019-0-PCT-02 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear PCT PCT PCT/US2021/030055 Expired
NIAID E-131-2019-0-PCT-02 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE PCT PCT PCT/US2021/029988 Expired
NIAID E-131-2019-0-CN-03 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE CN National Stage 202180046741.1 Pending
NIAID E-131-2019-0-EP-04 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE EP National Stage 21726787.1 Pending
NIAID E-131-2019-0-IN-05 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE IN National Stage 202217065780 Pending
NIAID E-038-2017-1-US-04 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US CON 17/243,455 11760794 Issued PDF
NCI E-085-2013-0-AU-30 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood AU DIV 2021202640 Issued
NCI E-229-2014-0-JP-12 METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS JP DIV 2021-076293 Issued
NCI E-125-2021-0-US-02 Methods And Materials For Large-Scale Assessment Of Ligand Binding Selectivity Of G-Quadruplex Recognition Using Custom G4 Microarrays US ORD 17/241,912 Pending
NCI E-520-2013-0-US-02 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US DIV 17/240,260 Pending
NCI E-078-2012-0-CA-11 Anti-Mesothelin Chimeric Antigen Receptors CA DIV 3116051 Issued
NCATS E-091-2016-0-US-08 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE US CON 17/237,351 11753408 Issued PDF
NCI E-176-2014-0-IL-60 Anti-Human Papillomavirus 16 E7 T Cell Receptors IL DIV 282518 Issued
NCI E-166-2018-0-AU-05 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS AU National Stage 2019364436 Pending
NHGRI E-054-2020-0-PCT-02 ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS PCT PCT PCT/US2021/028228 Expired
NCATS E-026-2016-0-TW-23 Compounds for Improving mRNA Splicing TW DIV 110113924 Pending
NIAID E-216-2018-2-US-02 MULTISPECIFIC ANTI-HIV ANTIBODIES US National Stage 17/285,956 Pending
NLM E-107-2010-2-US-33 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/231,671 11208683 Issued PDF
NIDDK E-108-2020-0-PCT-02 Thyclotides PCT PCT PCT/US2021/27397 Expired
NCI E-166-2018-0-CA-06 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CA National Stage 3116749 Pending
NCI E-176-2014-0-CN-59 Anti-Human Papillomavirus 16 E7 T Cell Receptors CN DIV 202110399056.9 Issued
NCI E-160-2018-0-US-06 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION US National Stage 17/285,453 Pending
NCI E-229-2014-0-AU-11 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU DIV 2021202223 Issued
NCI E-266-2011-0-CA-59 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage CA DIV 3114877 Issued
NCI E-176-2014-0-AU-58 Anti-Human Papillomavirus 16 E7 T Cell Receptors AU DIV 2021202227 Issued
NCI E-205-2010-2-JP-21 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2021-67756 Abandoned
NCI E-121-2020-2-PCT-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 PCT PCT COMB PCT/US2021/026883 Expired
NCATS E-022-2018-0-US-03 COMPOSITIONS AND METHODS FOR CELL CULTURE US National Stage 17/284,215 Pending
NCI E-040-2012-0-AU-63 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2021202158 Pending
NIAID E-135-2010-0-US-37 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 17/224,819 Pending
NIAID E-213-2021-2-US-05 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems US National Stage 17/282,447 Pending
NCI E-028-2015-1-JP-40 Anti-Mutated Kras T Cell Receptors JP DIV 2021-063092 Issued
NCI E-494-2013-0-HK-25 Methods of Preparing Anti-human Papillomavirus Antigen T Cells HK CN 42021028486.5 Pending